ProCE Banner Activity

How I Am Implementing the New ACIP Guidance on RSV Vaccination in My Practice

Clinical Thought

Read my commentary on recent RSV vaccine trials in older individuals and how to interpret the new ACIP guidance.

Released: September 20, 2023

Share

Faculty

Angela Branche

Angela Branche, MD, FIDSA

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline

Target Audience

This program is intended for physicians, pharmacists, physician associates/physician assistants, nurse practitioners, registered nurses, and other healthcare professionals who care for older adults at risk of RSV infection.

Program Learning Goal

The goal of this program is to improve healthcare professionals’ knowledge and competence regarding RSV infections and vaccines for older adults, including burden of disease, clinical manifestations, risk factors for severe disease, vaccine candidacy, and overcoming vaccination barriers.

Disclosure

Primary Author

Angela Branche, MD, FIDSA

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Angela Branche, MD, FIDSA: consultant/advisor/speaker: GlaxoSmithKline, Moderna, Novavax; researcher: CyanVac, Moderna, Pfizer, Vaccitech.